Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Case Report of Uterine Dedifferentiated Mesonephric-Like Adenocarcinoma With Comprehensive Molecular Profiling. | Int J Gynecol Pathol | 2026 | 40373225 | PubTator, text mining | PubMed |
| [Clinical Characteristics and Prognosis Analysis of Thoracic SMARCA4-deficient Undifferentiated Tumor versus SMARCA4-deficient Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2025 | 41777060 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing in Recurrent Pregnancy Loss: Current Evidence and Future Directions in Saudi Arabia. | Med Arch | 2025 | 41768206 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
| An Update on Clinically Advanced PROTAC Degraders and Their Synthesis. | Molecules | 2025 | 41515330 | PubTator, text mining | PubMed |
| Optical genome mapping uncovers clinically relevant structural variants in congenital heart disease with heterotaxy. | Front Genet | 2025 | 41427249 | PubTator, text mining | PubMed |
| SWI/SNF protein expression in anaplastic carcinomatous mural nodules of ovarian mucinous tumors. | Virchows Arch | 2025 | 41410734 | PubTator, text mining | PubMed |
| SWI/SNF chromatin remodeling factor BRAHMA promotes de novo shoot regeneration by epigenetic priming via H3K27me3 removal. | Plant J | 2025 | 41389184 | PubTator, text mining | PubMed |
| METTL3 and METTL14 determine human neural fate specifications. | Nucleic Acids Res | 2025 | 41385324 | PubTator, text mining | PubMed |
| Targeting of Brahma-related gene-1 (BRG1) overcomes paclitaxel-induced multidrug resistance caused by overexpression of the subset of ATP-binding cassette (ABC) transporters. | J Pharmacol Exp Ther | 2025 | 41371092 | PubTator, text mining | PubMed |
| Tumor-agnostic therapy: a potential therapeutic approach for SMARCA4-deficient malignancies. | Ther Adv Med Oncol | 2025 | 41367953 | PubTator, text mining | PubMed |
| [SWI/SNF complex-deficient sinonasal carcinomas: a clinicopathological analysis of 13 cases]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 41355104 | PubTator, text mining | PubMed |
| SMARCA2 is an essential and potent cofactor for a specific subset of the glucocorticoid response in A549 cells. | bioRxiv | 2025 | 41292984 | PubTator, text mining | PubMed |
| PHF10 is a Novel Substrate of Keap1 to Protect Non-Small-Cell Lung Cancer (NSCLC) Cells Against Oxidative Stress and Confer Ferroptosis Resistance. | Cancer Res Treat | 2025 | 41197527 | PubTator, text mining | PubMed |
| WNT signalling promotes NF-κB activation and drug resistance in KRAS-mutant colorectal cancer. | EMBO Rep | 2025 | 41188521 | PubTator, text mining | PubMed |
| Rational design of potent small-molecule SMARCA2/A4 degraders acting via the recruitment of FBXO22. | Nat Commun | 2025 | 41184243 | PubTator, text mining | PubMed |
| High glucose promotes cisplatin chemoresistance in MDA-MB-231 breast cancer derived cells through changes in gene expression and multiple signaling pathways. | Biomed Rep | 2025 | 41159042 | PubTator, text mining | PubMed |
| Whole-genome sequencing reveals individual and cohort level insights into chromosome 9p syndromes. | Genome Med | 2025 | 41137173 | PubTator, text mining | PubMed |
| Shifted assembly and function of mSWI/SNF family subcomplexes underlie targetable dependencies in dedifferentiated endometrial carcinomas. | Nat Genet | 2025 | 41116019 | PubTator, text mining | PubMed |
| Novel SMARCA2::DDIT3 Fusion in Primary Subcutaneous Myxoid Liposarcoma due to an Unusual Unbalanced Chromosomal Translocation. | Genes Chromosomes Cancer | 2025 | 41108625 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=5